Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesMT1-MMP controls human mesenchymal stem cell trafficking and differentiation
Blood, 11/25/09
Lu C et al. – These data demonstrate that hMSC invasion and differentiation programs fall under the control of the pericellular collagenase, MT1–MMP.
Related Articles
Plerixafor hydrochloride: A novel agent for the mobilization of peripheral blood stem cells
Drugs of Today, 11/05/09
Relevance Score: 82%
Stem cell therapy for age-related retinal disease
Aging Health, 11/23/09
Relevance Score: 70%
Neural stem cell therapy in neurological diseases
Archives of Medical Science, 11/02/09
Relevance Score: 70%
The cancer stem cell microenvironment and anti-cancer therapy
International Journal of Radiation Biology, 11/05/09
Relevance Score: 69%
Autologous Fibrin-Cultured Limbal Stem Cells Permanently Restore the Corneal Surface of Patients With Total Limbal Stem Cell Deficiency
Transplantation, 10/06/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation
BMC Cancer, 02/09/10
TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer
Genes, Chromosomes and Cancer, 02/09/10
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Cancer Chemotherapy and Pharmacology, 02/09/10
Article Search
Sponsor
Sponsor